BiotechTube
Home/Contineum Therapeutics/Dr. Mark McDonnell
DM

Dr. Mark McDonnell

Chief Scientific Officer

Contineum Therapeutics

Therapeutic Areas

NeuroscienceImmunologyInflammation

Contineum Therapeutics Pipeline

DrugIndicationPhase
PIPE-307Relapsing Remitting Multiple SclerosisPhase 2
PIPE-791Idiopathic Pulmonary FibrosisPhase 1
PIPE-505UndisclosedPreclinical

Leadership Team at Contineum Therapeutics

DC
Dr. Carmine Stengone
President & Chief Executive Officer
DS
Dr. Srinivas Rao
Chief Medical Officer
VC
Vickie Capps
Chief Financial Officer
View full Contineum Therapeutics profile